Literature DB >> 20950410

Growth pattern and growth prediction of body height in children with mucopolysaccharidosis type II.

Agnieszka Rozdzynska1, Anna Tylki-Szymanska, Agnieszka Jurecka, Joachim Cieslik.   

Abstract

AIM: Our goal was to evaluate the level, degree and direction of deviation in the ontogenesis of patients with mucopolysaccharidosis type II (MPS II) in comparison with the healthy population.
MATERIAL AND METHODS: The anthropometric data of a longitudinal study on 28 patients with MPS II, aged from 0.5 to 21 years, were used to analyse the general growth patterns in terms of height, weight and head circumference. The growth trend was assessed with the straight-line regression model. The mathematical structural growth model was used to evaluate the structure of body height growth.
RESULTS: A statistically significant negative growth trend for all features was found. Analysis of development structure revealed an earlier onset of the adolescent growth spurt among healthy boys and a lower current velocity of growth than expected values.
CONCLUSION: During the first 3 years of life, all observed anthropometric features grew faster than normal. They slowed down by the end of the third year and, in subsequent years, reached lower values when compared with the reference charts. The values obtained from the BTT model showed the structure of body height growth, with particular emphasis on the pubertal spurt, was significantly different from the reference charts.
© 2010 The Author(s)/Acta Paediatrica © 2010 Foundation Acta Paediatrica.

Entities:  

Mesh:

Year:  2010        PMID: 20950410     DOI: 10.1111/j.1651-2227.2010.02060.x

Source DB:  PubMed          Journal:  Acta Paediatr        ISSN: 0803-5253            Impact factor:   2.299


  16 in total

1.  Growth in patients with mucopolysaccharidosis type III (Sanfilippo disease).

Authors:  J de Ruijter; L Broere; M F Mulder; A T van der Ploeg; M E Rubio-Gozalbo; S B Wortmann; G Visser; F A Wijburg
Journal:  J Inherit Metab Dis       Date:  2013-10-31       Impact factor: 4.982

2.  Growth patterns in children with mucopolysaccharidosis I and II.

Authors:  Agnieszka Różdżyńska-Świątkowska; Agnieszka Jurecka; Joachim Cieślik; Anna Tylki-Szymańska
Journal:  World J Pediatr       Date:  2014-11-20       Impact factor: 2.764

3.  Di-sulfated Keratan Sulfate as a Novel Biomarker for Mucopolysaccharidosis II, IVA, and IVB.

Authors:  Tsutomu Shimada; Shunji Tomatsu; Robert W Mason; Eriko Yasuda; William G Mackenzie; Jobayer Hossain; Yuniko Shibata; Adriana M Montaño; Francyne Kubaski; Roberto Giugliani; Seiji Yamaguchi; Yasuyuki Suzuki; Kenji E Orii; Toshiyuki Fukao; Tadao Orii
Journal:  JIMD Rep       Date:  2015-02-25

4.  Impact of enzyme replacement therapy on linear growth in Korean patients with mucopolysaccharidosis type II (Hunter syndrome).

Authors:  Sung Yoon Cho; Rimm Huh; Mi Sun Chang; Jieun Lee; Younghee Kwun; Se Hyun Maeng; Su Jin Kim; Young Bae Sohn; Sung Won Park; Eun-Kyung Kwon; Sun Ju Han; Jooyoun Jung; Dong-Kyu Jin
Journal:  J Korean Med Sci       Date:  2014-01-28       Impact factor: 2.153

Review 5.  Failures of Endochondral Ossification in the Mucopolysaccharidoses.

Authors:  Zhirui Jiang; Sharon Byers; Margret L Casal; Lachlan J Smith
Journal:  Curr Osteoporos Rep       Date:  2020-10-16       Impact factor: 5.096

6.  Diagnosing Hunter syndrome in pediatric practice: practical considerations and common pitfalls.

Authors:  Barbara K Burton; Roberto Giugliani
Journal:  Eur J Pediatr       Date:  2012-03-01       Impact factor: 3.183

7.  The effect of recombinant human iduronate-2-sulfatase (Idursulfase) on growth in young patients with mucopolysaccharidosis type II.

Authors:  Zbigniew Żuber; Agnieszka Różdżyńska-Świątkowska; Agnieszka Jurecka; Anna Tylki-Szymańska
Journal:  PLoS One       Date:  2014-01-13       Impact factor: 3.240

8.  Growth charts for patients with Hunter syndrome.

Authors:  Pravin Patel; Yasuyuki Suzuki; Miho Maeda; Eriko Yasuda; Tsutomu Shimada; Kenji E Orii; Tadao Orii; Shunji Tomatsu
Journal:  Mol Genet Metab Rep       Date:  2014

9.  Long-term therapeutic efficacy of allogenic bone marrow transplantation in a patient with mucopolysaccharidosis IVA.

Authors:  Yasutsugu Chinen; Takeshi Higa; Shunji Tomatsu; Yasuyuki Suzuki; Tadao Orii; Nobuyuki Hyakuna
Journal:  Mol Genet Metab Rep       Date:  2014

10.  Anthropometric characteristics of four Polish children with mucopolysaccharidosis.

Authors:  Lidia Perenc
Journal:  BMC Res Notes       Date:  2013-07-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.